Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Journal of Neurology
|
August 1, 2022
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
Karim L Kreft, Neil P Robertson
Practical Neurology
|
June 27, 2024
Oligoclonal bands
Mark D Willis, Karim L Kreft, Bethan Dancey
Journal of the Neurological Sciences
|
February 3, 2009
Spinal cord involvement in Balo's concentric sclerosis
Karim L Kreft, S Jouke Mellema, Rogier Q Hintzen
Journal of Neurology
|
February 11, 2024
Prodromal multiple sclerosis: considerations and future utility
Katharine E Harding, Karim L Kreft, Yoav Ben-Shlomo, et al.
Brain : a Journal of Neurology
|
March 27, 2026
Interplay between genetic and environmental risk factors in multiple sclerosis: what have we learned?
Benjamin M Jacobs, Marijne Vandebergh, Vicki E Maltby, et al.
Annals of Neurology
|
March 15, 2011
Role of CD8 regulatory T-cells in multiple sclerosis
Karim L Kreft, Evert Verbraak, Annet F Wierenga-Wolf, et al.
Journal of Neuroinflammation
|
December 13, 2012
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation
Ruth Huizinga, Karim L Kreft, Sabina Onderwater, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 16, 2020
EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution
Julia Y Mescheriakova, Gijsbert P van Nierop, Annemiek A van der Eijk, et al.
Nature Reviews. Neurology
|
November 27, 2025
Towards primary prevention of multiple sclerosis
Ruth Dobson, Karim L Kreft, Benjamin M Jacobs, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 31, 2018
Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants
Karim L Kreft, Gijsbert P Van Nierop, Sandra M J Scherbeijn, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Journal of Neurology
|
August 1, 2022
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
Karim L Kreft, Neil P Robertson
Practical Neurology
|
June 27, 2024
Oligoclonal bands
Mark D Willis, Karim L Kreft, Bethan Dancey
Journal of the Neurological Sciences
|
February 3, 2009
Spinal cord involvement in Balo's concentric sclerosis
Karim L Kreft, S Jouke Mellema, Rogier Q Hintzen
Journal of Neurology
|
February 11, 2024
Prodromal multiple sclerosis: considerations and future utility
Katharine E Harding, Karim L Kreft, Yoav Ben-Shlomo, et al.
Brain : a Journal of Neurology
|
March 27, 2026
Interplay between genetic and environmental risk factors in multiple sclerosis: what have we learned?
Benjamin M Jacobs, Marijne Vandebergh, Vicki E Maltby, et al.
Annals of Neurology
|
March 15, 2011
Role of CD8 regulatory T-cells in multiple sclerosis
Karim L Kreft, Evert Verbraak, Annet F Wierenga-Wolf, et al.
Journal of Neuroinflammation
|
December 13, 2012
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation
Ruth Huizinga, Karim L Kreft, Sabina Onderwater, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 16, 2020
EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution
Julia Y Mescheriakova, Gijsbert P van Nierop, Annemiek A van der Eijk, et al.
Nature Reviews. Neurology
|
November 27, 2025
Towards primary prevention of multiple sclerosis
Ruth Dobson, Karim L Kreft, Benjamin M Jacobs, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 31, 2018
Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants
Karim L Kreft, Gijsbert P Van Nierop, Sandra M J Scherbeijn, et al.
Page
of 3